ASA Gold and Precious Metals Ltd C.ASA

Primary Symbol: ASA

ASA Gold and Precious Metals Limited is a non-diversified, closed-end investment company. The Company's investment objective is long-term capital appreciation primarily through investing in companies engaged in the exploration for, development of projects or mining of precious metals and minerals. The Company invests approximately 80% of its total assets in common shares or securities convertible into common shares of companies engaged, directly or indirectly, in the exploration, mining or processing of gold, silver, platinum, diamonds or other precious minerals; held as bullion or other direct forms of gold, silver, platinum or other precious minerals; in instruments representing interests in gold, silver, platinum or other precious minerals, and/or in securities of investment companies, including exchange traded funds, or other securities. The Company’s investment adviser is Merk Investments LLC.

NYSE:ASA - Post by User

ASA Gold and Precious Metals Ltd > New medipharm article gives light on potential revenues.

<< Previous

Bullboard Posts

Next >>

Post by Coffeeukeon Feb 12, 2019 9:20am

142 Views

Post# 29351795

New medipharm article gives light on potential revenues.

Medipharm just signed a pretty nice deal, with a guarentee of over $7m in February alone. Gives some insight into the potential gross revenues of their 4 deals. A potential trial of $85m over the next 15 months on those contracts alone is impressive, seems to outline this is based on their current 150k kg capacity. https://www.newcannabisventures.com/cannabis-oil-supplier-medipharm-labs-signs-35-million-minimum-supply-deal-with-canadian-licensed-producer/

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features